Discovery of a Selective Inhibitor of ZIP14 with Therapeutic Potential for Cancer-associated Cachexia
Authors:
- Takafumi HaraTHTakafumi Hara
- Gen TanakaGTGen Tanaka
- Tomonori TamuraTTTomonori Tamura
- Masaomi TerajimaMTMasaomi Terajima
- Kengo HamamuraKHKengo Hamamura
- Yuya YoshidaYYYuya Yoshida
- Toru KimuraTKToru Kimura
- Yusuke KasaiYKYusuke Kasai
- Yuta NakayamaYNYuta Nakayama
- Takumi UmeyamaTUTakumi Umeyama
- Kohei HosoiKHKohei Hosoi
- Ayaka NoguchiANAyaka Noguchi
Preprint
Abstract
ZIP14/SLC39A14, a membrane-bound metal transporter, is essential for systemic metal homeostasis and has been implicated in inflammatory and metabolic disorders, including cancer-associated cachexia. Despite its biological and therapeutic significance, no selective inhibitors have been identified. Here, we identify 1-phenyl-8-(2-phenylethyl)-1,3,8-triazaspiro[4.5]decan-4-one (PPTD) as the first selective small-molecule inhibitor of ZIP14. PPTD efficiently blocks ZIP14-mediated uptake of zinc, iron, manganese, and cadmium, while sparing the closely related transporter ZIP8/SLC39A8. Mechanistically, PPTD binds specifically to a pocket formed at the dimer interface of ZIP14, as revealed by AlphaFold3 structural prediction, ligand–interaction profiling, structure–activity analyses, and site-directed mutagenesis, providing direct evidence for a targeted inhibition mechanism. ZIP14-driven metal influx promotes reactive oxygen species and lipid peroxidation, leading to cytotoxicity, which PPTD effectively reverses. In vivo , PPTD ameliorates major features of cancer cachexia in mice, including weight loss, reduced survival, muscle wasting, impaired locomotor activity, and disease progression. PPTD thus provides both a chemical probe to dissect ZIP14 function and a potential therapeutic candidate for cancer cachexia, establishing a foundation for the development of therapies targeting ZIP14-mediated metal dysregulation.Keywords
This publication has 46 references indexed in Scilit:
- Inhibitors of Human Divalent Metal Transporters DMT1 (SLC11A2) and ZIP8 (SLC39A8) from a GDB‐17 Fragment LibraryChemMedChem, 2021
- The ZIP6/ZIP10 heteromer is essential for the zinc-mediated trigger of mitosisCellular and Molecular Life Sciences, 2020
- Trace Elements and Healthcare: A Bioinformatics Perspective2017
- Autosomal-Recessive Intellectual Disability with Cerebellar Atrophy Syndrome Caused by Mutation of the Manganese and Zinc Transporter Gene SLC39A8The American Journal of Human Genetics, 2015
- SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary HemochromatosisCell Metabolism, 2015
- Non-transferrin bound iron: A key role in iron overload and iron toxicityBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Physiologic implications of metal-ion transport by ZIP14 and ZIP8BioMetals, 2012
- Spondylocheiro Dysplastic Form of the Ehlers-Danlos Syndrome—An Autosomal-Recessive Entity Caused by Mutations in the Zinc Transporter Gene SLC39A13The American Journal of Human Genetics, 2008
- Discovery of N-(2-aryl-cyclohexyl) substituted spiropiperidines as a novel class of GlyT1 inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Mycobacterium bovis BCG Cell Wall and Lipopolysaccharide Induce a Novel Gene, BIGM103, Encoding a 7-TM Protein: Identification of a New Protein Family Having Zn-Transporter and Zn-Metalloprotease SignaturesGenomics, 2002